Crossmark

Avoiding treatment failures associated with HCV resistance

Crossref DOI link: https://doi.org/10.1038/nrgastro.2015.184

Published Online: 2015-10-27

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pawlotsky, Jean-Michel
License Information

Text and Data Mining valid from 2015-10-27
More Information

Article History

First Online: 27 October 2015

Competing interests

: J.M.P. has received research grants from Gilead Sciences and has served as an advisor for Abbvie, Bristol-Myers Squibb, Gilead Sciences, Janssen and Merck.